160 Participants Needed

Central Venous Catheter Techniques for Shock

JO
BF
Overseen ByBenjamin Friedman, MD
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Montefiore Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 6 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Two different techniques for placing a central venous catheter will be compared. The studyu team hypothesizes that clinicians randomized to the peripheral catheter technique will have higher first attempt success rates, fewer procedural complications, and a shorter mean time to procedure completion than physicians assigned to wire through hollow bore needle.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it mentions that patients using aspirin or other anti-platelet medications are not excluded.

What data supports the effectiveness of the treatment Central venous catheter insertion for shock?

Central venous catheter placement is a crucial procedure in emergency medicine for administering fluids and medications, and it is frequently used in critical care settings. It is considered effective for providing vascular access in patients with chronic conditions, such as renal failure, and is essential for monitoring and treatment in various medical situations.12345

Is central venous catheter insertion generally safe for humans?

Central venous catheter (CVC) insertion is a common procedure but can cause complications like infections, blood clots, and mechanical issues in about 15% of cases. Proper technique and monitoring by a specialized team can help reduce these risks.36789

How is central venous catheter insertion unique compared to other treatments for shock?

Central venous catheter insertion is unique because it involves placing a tube directly into a large vein near the heart to deliver medications or fluids quickly and monitor heart function, which is crucial in emergency situations like shock. Unlike other treatments, it uses ultrasound guidance to ensure accurate placement and reduce complications, making it a precise and effective method for managing severe conditions.45101112

Research Team

Dr. Benjamin W. Friedman, MD | Bronx ...

Benjamin W Friedman, MD

Principal Investigator

Montefiore Medical Center

Eligibility Criteria

This trial is for adult patients in the emergency department who need a central venous catheter placed using ultrasound guidance. People with existing catheters that could interfere, blood clotting issues, low platelet counts, previous central lines at the same site, or conditions affecting consent are not eligible.

Inclusion Criteria

Adult patients in the emergency department who require ultrasound guided central line placement are eligible for participation and will be referred for participation in the study by the clinical team.

Exclusion Criteria

Anterior border of the target vein deeper than 3.5cm
Previous central venous access at the same anatomical site.
Any indwelling catheter or wire that could potentially interfere with central line placement
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo central venous catheter insertion using either the standard hollow bore needle technique or the peripheral IV catheter technique

20 minutes
1 visit (in-person)

Follow-up

Participants are monitored for procedure-related adverse events and success rates

1 week

Treatment Details

Interventions

  • Central venous catheter insertion
Trial OverviewThe study compares two different techniques of inserting a central venous catheter to see which one might be better. Patients will receive one of these techniques when they require a central line during their emergency care.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Peripheral IVExperimental Treatment1 Intervention
A peripheral intravenous catheter will be used to obtain initial central venous access
Group II: Standard techniqueActive Control1 Intervention
The conventional hollow bore needle on a syringe will be used

Central venous catheter insertion is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:

🇪🇺
Approved in European Union as Central venous catheter insertion for:
  • Administration of vesicant or irritant medications
  • Vasopressors
  • Chemotherapy
  • Total parenteral nutrition
  • Poor peripheral IV access
  • Renal replacement therapy
  • Plasmapheresis
  • Apheresis
  • Transvenous pacing
  • Mixed venous O2 monitoring
  • CVP monitoring
🇺🇸
Approved in United States as Central venous catheter insertion for:
  • Administration of vesicant or irritant medications
  • Vasopressors
  • Chemotherapy
  • Total parenteral nutrition
  • Poor peripheral IV access
  • Renal replacement therapy
  • Plasmapheresis
  • Apheresis
  • Transvenous pacing
  • Mixed venous O2 monitoring
  • CVP monitoring
🇨🇦
Approved in Canada as Central venous catheter insertion for:
  • Administration of vesicant or irritant medications
  • Vasopressors
  • Chemotherapy
  • Total parenteral nutrition
  • Poor peripheral IV access
  • Renal replacement therapy
  • Plasmapheresis
  • Apheresis
  • Transvenous pacing
  • Mixed venous O2 monitoring
  • CVP monitoring
🇯🇵
Approved in Japan as Central venous catheter insertion for:
  • Administration of vesicant or irritant medications
  • Vasopressors
  • Chemotherapy
  • Total parenteral nutrition
  • Poor peripheral IV access
  • Renal replacement therapy
  • Plasmapheresis
  • Apheresis
  • Transvenous pacing
  • Mixed venous O2 monitoring
  • CVP monitoring
🇨🇳
Approved in China as Central venous catheter insertion for:
  • Administration of vesicant or irritant medications
  • Vasopressors
  • Chemotherapy
  • Total parenteral nutrition
  • Poor peripheral IV access
  • Renal replacement therapy
  • Plasmapheresis
  • Apheresis
  • Transvenous pacing
  • Mixed venous O2 monitoring
  • CVP monitoring
🇨🇭
Approved in Switzerland as Central venous catheter insertion for:
  • Administration of vesicant or irritant medications
  • Vasopressors
  • Chemotherapy
  • Total parenteral nutrition
  • Poor peripheral IV access
  • Renal replacement therapy
  • Plasmapheresis
  • Apheresis
  • Transvenous pacing
  • Mixed venous O2 monitoring
  • CVP monitoring

Find a Clinic Near You

Who Is Running the Clinical Trial?

Montefiore Medical Center

Lead Sponsor

Trials
468
Recruited
599,000+

Findings from Research

In a study involving 409 patients with chronic renal failure, the use of angiographic techniques for central venous catheter placement resulted in a high success rate, with only 4.4% requiring alternative methods due to guidewire advancement issues.
The procedure was found to be safe, with only one case of severe arrhythmia reported, indicating that angiographic techniques can effectively minimize complications in patients with a history of multiple catheterizations.
Insertion of central venous catheters for hemodialysis using angiographic techniques in patients with previous multiple catheterizations.Kotsikoris, I., Zygomalas, A., Papas, T., et al.[2016]
A rare complication of central venous catheter placement is the development of a pseudoaneurysm in the inferior thyroid artery, which can occur due to accidental puncture during internal jugular vein cannulation.
Using ultrasound guidance during venipuncture significantly reduces the risk of mechanical complications, highlighting its importance in safely performing central line placements.
Inferior thyroid artery pseudoaneurysm associated with internal jugular vein puncture: a case report.Ruan, J., Zhang, C., Peng, Z., et al.[2022]
In a study of 121 pediatric patients who underwent central venous catheter (CVC) insertion in the emergency department, the most common reasons for insertion were lack of peripheral vascular access (64%) and cardiac/respiratory arrest (17%).
The femoral vein was the primary site for CVC insertion (83%), and while there were some complications, none were life-threatening, indicating that CVC placement, especially via the femoral approach, is a safe procedure for critically ill children.
Uses and complications of central venous catheters inserted in a pediatric emergency department.Chiang, VW., Baskin, MN.[2022]

References

Insertion of central venous catheters for hemodialysis using angiographic techniques in patients with previous multiple catheterizations. [2016]
Inferior thyroid artery pseudoaneurysm associated with internal jugular vein puncture: a case report. [2022]
Uses and complications of central venous catheters inserted in a pediatric emergency department. [2022]
Bedside prediction of the central venous catheter insertion depth - Comparison of different techniques. [2022]
Long-term venous access: indications and choice of site and catheter. [2005]
[How to improve central venous catheter use in intensive care unit?]. [2006]
Persistent Left Superior Vena Cava Identified After Hemodialysis Catheter Insertion: A Case Report. [2022]
Adverse events related to the use of central venous catheters in hospitalized newborns. [2019]
Inserting central venous catheter in emergency conditions in coagulopathic patients in comparison to noncoagulopathic patients. [2020]
Central venous access. [2020]
11.United Statespubmed.ncbi.nlm.nih.gov
Central venous catheterization in the critically ill patient. [2005]
12.United Statespubmed.ncbi.nlm.nih.gov
Use of Point-of-Care Ultrasound to Confirm Central Venous Catheter Placement and Evaluate for Postprocedural Complications. [2021]